Aspira Women's Health Inc.
AWHL· OTC
AWHLAspira Women's Health Inc.
Released Nov 14, 2024, during market hours
10-Q filed Nov 19, 2024, 50 days after period end · 0001493152-24-046836
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | $2.26M | $2.22M | $2.07M | $1.67M |
| Net Income | -$3.55M | -$4.71M | -$7.78M | -$9.71M |
| EPS Diluted |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$0.23 |
| -$0.48 |
| -$1.00 |
| -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
